Highlights of the important and interesting in the world of healthcare:
Eli Lilly leases cancer lab in Big Apple. Indianapolis drug maker Eli Lilly and Co. — pushing to make a name for itself in cancer research after buying ImClone for $6.5 billion in 2008 — has moved about 140 of its oncology researchers into a brand-new research center it is leasing in New York City, according to the Indianapolis Star.
Simplifed Framingham model could be wrong. Physicians who use a simplified version of the Framingham risk assessment tool may be miscalculating patients’ likelihood of a major coronary event, according to a new study reported in American Medical News.
Immune Support on Demand: Ranking the Top Mobile IV Therapy Companies
Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S.
Birth control pill, and then some. Bayer is putting folate in its birth control pill Yaz — to protect babies of women for whom the pill fails. That’s “crazy weirdness,” points out blogger Nostrums… by Doc D.
Slipping through (electronic) cracks. Insurers and health-care providers are turning to closed claims from past malpractice cases to teach doctors how to avoid some of the most common diagnostic errors, such as when an abnormal test result falls through the cracks, according to the Wall Street Journal Health blog.
Another IPO for Quintiles? Dennis Gillings, founder and CEO of pharmaceutical services company Quintiles Transnational, told Bloomberg News in a phone interview from Australia that an initial public offering of stock would allow his Durham, North Carolina-based company to raise money to expand in Asia, reports the News & Observer.
J&J on the Congressional hot seat. Johnson & Johnson CEO William C. Weldon is expected to appear at a Congressional hearing Thursday to tell lawmakers his own account of the manufacturing problems that led to recalls of popular over-the-counter drugs like children’s liquid Tylenol, according to the New York Times.